Skip to main content

Table 1 Demographic and clinical characteristics of the group of 29 patients with resistant Social Anxiety Disorder (SAD) enrolled in the study.

From: Resistant social anxiety disorder response to Escitalopram

Age m: 34.6 sd: 9.9 (range 24–42)  
Gender 13 M (44.8%)/16 F (55.2%)  
Education level (yrs) m: 12.3 sd: 4.6  
Marital status Single n = 9 (31%)  
  Married n = 16 (55.2%)  
  Divorced n = 4 (13.8%)  
Duration of SAD (yrs) m: 12.9 sd: 7.3  
Baseline LSAS score m: 62.4 sd: 10.6  
Baseline HSRD score m: 12.68 sd: 2.42  
Baseline CGI-S m: 4.8 sd: 1.1  
CGI-I (Paroxetine trial) m: 4.3 sd: 0.5  
Baseline SDS Work m: 7.6 sd: 1.8  
Baseline SDS Social m: 8.5 sd: 2.0  
Baseline SDS Family m: 5.2 sd: 1.3  
Baseline ASEX m: 19.4 sd: 2.3  
Lifetime comorbidity   
   Axis I Depressive disorder 5 (17.2%)
  Cyclothimia 2 (6.9%)
  Panic disorder 6 (20.7%)
  Somatoform disorder 3 (10.3%)
  Obsessive-Compulsive Dis. 2 (6.9%)
  Alcohol abuse 5 (17.2%)
  Substance abuse 2 (6.9%)
   Axis 2 Avoidant PD 4 (13.8%)
  Obsessive-Compulsive PD 1 (3.4%)
  Passive-Aggressive PD 1 (3.4%)
  Narcissistic PD 1 (3.4%)
  1. Key:
  2. LSAS: Liebowitz Scale for Social Anxiety.
  3. HSRD: Hamilton Depression Rating Scale.
  4. CGI-S: Clinical Global Inventory-Severity.
  5. CGI-I: Clinical Global Inventory-Improvement.
  6. SDS: Sheehan Disability Scale.
  7. ASEX: Arizona Sexual Experience Scale.